{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:16:13Z","timestamp":1780085773349,"version":"3.54.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012533","name":"Minia University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012533","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to detect the changes in certain immunological parameters and miRNAs in COVID-19 cases with various degrees of disease severity and compare these changes in cases to healthy controls. This study was conducted on 45 COVID\u201019 patients and 45 healthy controls. The flow cytometry was conducted to study the number of CD4\u2009+\u2009and CD8\u2009+\u2009T cells and evaluate the level of the PD-1 marker on their surfaces for all study participants. The determination of IL-1\u03b2 and IL-6 in serum for all study subjects was done by ELISA test. Relative gene expression quantitation of miR-146a and miR-133a was performed by reverse transcriptase real-time PCR (RT-PCR). The numbers of CD4\u2009+\u2009and CD8\u2009+\u2009T cells were dramatically reduced in COVID-19 patients, especially in severe to critical patients, with an increase in the CD4\u2009+\u2009:CD8\u2009+\u2009ratio. T cells from COVID-19 patients had significantly higher levels of the exhausted marker PD-1. Measurement of IL-1\u03b2 and IL-6 serum levels among cases group showed a highly significant increase in their mean concentration levels in comparison with the control group. Studying the difference in serum levels of IL-1\u03b2 and IL-6 among different degrees of disease severity showed a significant decrease in their mean concentration levels among the mild to moderate group in comparison with the severe to critical group. The results also showed a significant decrease in miR-146a and a significant increase in miR-133a expression in COVID-19 patients compared to healthy controls. Reduced T cell counts, increased CD4\u2009+\u2009:CD8\u2009+\u2009ratio, higher levels of the PD-1 marker, elevated serum levels of the pro-inflammatory cytokines, and decreased miR-146a and increased miR-133a gene expressions could be used as potential markers in the assessment of COVID-19 infection and severity.<\/jats:p>","DOI":"10.1038\/s41598-025-34444-y","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T10:36:25Z","timestamp":1769682985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential predictors of COVID-19 disease infection and severity in Egypt"],"prefix":"10.1038","volume":"16","author":[{"given":"Wedad M.","family":"Abdelraheem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghda Raouf","family":"Shady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa K. M.","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ibrahim","family":"Bassyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba S.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiamaa F.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal Mohamed","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha S.","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"8","key":"34444_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166154","volume":"1867","author":"AN Zekri","year":"2021","unstructured":"Zekri, A. N. et al. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes. Biochim. Biophys. Acta 1867(8), 166154 (2021).","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"34444_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4103\/IJPM.IJPM_779_20","volume":"63","author":"A Bal","year":"2020","unstructured":"Bal, A., Agrawal, R., Vaideeswar, P., Arava, S. & Jain, A. COVID-19: An up-to-date review\u2014From morphology to pathogenesis. Indian J. Pathol. Microbiol. 63(3), 358\u2013366 (2020).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"34444_CR3","doi-asserted-by":"crossref","unstructured":"Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, Caricchio R, Mahmud S, Hazen MM, Halyabar OJA et al: On the alert for cytokine storm: immunopathology in COVID\u201019. 2020, 72(7):1059\u20131063.","DOI":"10.1002\/art.41285"},{"issue":"4","key":"34444_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184(4), 861\u2013880 (2021).","journal-title":"Cell"},{"issue":"6","key":"34444_CR5","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.21873\/invivo.12626","volume":"35","author":"MG Detsika","year":"2021","unstructured":"Detsika, M. G. et al. Combination of the CD8(+):B-cell and neutrophil-to-lymphocyte ratio as a novel prediction model for intubation need and disease severity in COVID-19 patients. In Vivo 35(6), 3305\u20133313 (2021).","journal-title":"In Vivo"},{"issue":"7","key":"34444_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/art.41285","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson, L. A. et al. On the alert for cytokine storm: Immunopathology in COVID-19. Arthrit. Rheumatol 72(7), 1059\u20131063 (2020).","journal-title":"Arthrit. Rheumatol"},{"issue":"3","key":"34444_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/advances\/nmaa125","volume":"12","author":"R Silverio","year":"2021","unstructured":"Silverio, R., Gon\u00e7alves, D. C., Andrade, M. F. & Seelaender, M. Coronavirus disease 2019 (COVID-19) and nutritional status: the missing link?. Adv. Nutr 12(3), 682\u2013692 (2021).","journal-title":"Adv. Nutr"},{"key":"34444_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111413","volume":"193","author":"J Sabbatinelli","year":"2021","unstructured":"Sabbatinelli, J. et al. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech. Ageing Dev. 193, 111413 (2021).","journal-title":"Mech. Ageing Dev."},{"issue":"2","key":"34444_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/cvr\/cvab338","volume":"118","author":"C Gutmann","year":"2022","unstructured":"Gutmann, C. et al. Association of cardiometabolic microRNAs with COVID-19 severity and mortality. Cardiovasc. Res. 118(2), 461\u2013474 (2022).","journal-title":"Cardiovasc. Res."},{"key":"34444_CR10","unstructured":"Masoud H, Elassal G, Zaky S, Baki A, Ibrahem H, Amin W, Abdelbary A, Abdalmohsen A, Hassany M, Eid A et al: Management Protocol for COVID-19 Patients Version 1.4\/30th May 2020 Ministry of health and population (MOHP), Egypt. In.; 2020."},{"issue":"14","key":"34444_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.46234\/ccdcw2022.074","volume":"4","author":"M Li","year":"2022","unstructured":"Li, M. et al. Association of COVID-19 vaccination and clinical severity of patients infected with delta or omicron variants\u2014China, May 21, 2021-February 28, 2022. China CDC Wkly 4(14), 293\u2013297 (2022).","journal-title":"China CDC Wkly"},{"issue":"11","key":"34444_CR12","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/cam4.874","volume":"5","author":"W Zhang","year":"2016","unstructured":"Zhang, W. et al. PD-1 expression on the surface of peripheral blood CD4(+) T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma. Cancer Med. 5(11), 3077\u20133084 (2016).","journal-title":"Cancer Med."},{"issue":"6","key":"34444_CR13","first-page":"7225","volume":"14","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Zhu, W., Zhang, X., Qu, Q. & Zhang, L. Expression and clinical significance of programmed death-1 on lymphocytes and programmed death ligand-1 on monocytes in the peripheral blood of patients with cervical cancer. Oncol. Lett. 14(6), 7225\u20137231 (2017).","journal-title":"Oncol. Lett."},{"key":"34444_CR14","doi-asserted-by":"crossref","unstructured":"Ostrycharz E, Hukowska-Szematowicz B: Micro-players of great significance\u2014Host microRNA signature in viral infections in humans and animals. 2022, 23(18):10536.","DOI":"10.3390\/ijms231810536"},{"issue":"10","key":"34444_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18(10), 997\u20131006 (2008).","journal-title":"Cell Res."},{"issue":"5101","key":"34444_CR16","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1126\/science.259.5101.1594","volume":"259","author":"SW McElvany","year":"1993","unstructured":"McElvany, S. W., Ross, M. M., Goroff, N. S. & Diederich, F. Cyclocarbon coalescence: Mechanisms for tailor-made fullerene formation. Science 259(5101), 1594\u20131596 (1993).","journal-title":"Science"},{"issue":"10223","key":"34444_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395(10223), 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"34444_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644095","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy, H. M. et al. COVID-19 in relation to hyperglycemia and diabetes mellitus. Front. Cardiovasc. Med. 8, 644095 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"34444_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1148\/radiol.2020200370","volume":"295","author":"F Pan","year":"2020","unstructured":"Pan, F. et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 295(3), 715\u2013721 (2020).","journal-title":"Radiology"},{"issue":"7798","key":"34444_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798), 270\u2013273 (2020).","journal-title":"Nature"},{"issue":"2","key":"34444_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/jmv.26389","volume":"93","author":"RK Reddy","year":"2021","unstructured":"Reddy, R. K. et al. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J. Med. Virol. 93(2), 1045\u20131056 (2021).","journal-title":"J. Med. Virol."},{"issue":"4","key":"34444_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jrh.12481","volume":"36","author":"BG Kaufman","year":"2020","unstructured":"Kaufman, B. G., Whitaker, R., Pink, G. & Holmes, G. M. Half of rural residents at high risk of serious illness due to COVID-19, creating stress on rural hospitals. J Rural Health Off J Am. Rural Health Assoc. Nat. Rural Health Care Assoc 36(4), 584\u2013590 (2020).","journal-title":"J Rural Health Off J Am. Rural Health Assoc. Nat. Rural Health Care Assoc"},{"key":"34444_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1088","volume":"373","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal, J. et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ 373, n1088 (2021).","journal-title":"BMJ"},{"issue":"6","key":"34444_CR24","first-page":"440","volume":"123","author":"YI Sezen","year":"2022","unstructured":"Sezen, Y. I. et al. Risk factors and the impact of vaccination on mortality in COVID-19 patients. Bratisl. Lek. Listy 123(6), 440\u2013443 (2022).","journal-title":"Bratisl. Lek. Listy"},{"key":"34444_CR25","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.2147\/IDR.S263489","volume":"13","author":"AA Ghweil","year":"2020","unstructured":"Ghweil, A. A. et al. Characteristics, outcomes and indicators of severity for COVID-19 among sample of ESNA quarantine hospital\u2019s patients, Egypt: A retrospective study. Infect. Drug Resist. 13, 2375\u20132383 (2020).","journal-title":"Infect. Drug Resist."},{"issue":"10223","key":"34444_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395(10223), 514\u2013523 (2020).","journal-title":"Lancet"},{"issue":"11","key":"34444_CR27","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","volume":"221","author":"F Wang","year":"2020","unstructured":"Wang, F. et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J. Infect. Dis. 221(11), 1762\u20131769 (2020).","journal-title":"J. Infect. Dis."},{"issue":"7","key":"34444_CR28","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.3390\/nu13072199","volume":"13","author":"N Charoenngam","year":"2021","unstructured":"Charoenngam, N., Alexanian, S. M., Apovian, C. M. & Holick, M. F. Association between hyperglycemia at hospital presentation and hospital outcomes in COVID-19 patients with and without type 2 diabetes: A retrospective cohort study of hospitalized inner-city COVID-19 patients. Nutrients 13(7), 2199 (2021).","journal-title":"Nutrients"},{"issue":"4","key":"34444_CR29","doi-asserted-by":"publisher","first-page":"e0250147","DOI":"10.1371\/journal.pone.0250147","volume":"16","author":"DL Ramatillah","year":"2021","unstructured":"Ramatillah, D. L. & Isnaini, S. Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta. PLoS ONE 16(4), e0250147 (2021).","journal-title":"PLoS ONE"},{"issue":"36","key":"34444_CR30","doi-asserted-by":"publisher","first-page":"039463202210962","DOI":"10.1177\/03946320221096207","volume":"22","author":"LA Fathalla","year":"2022","unstructured":"Fathalla, L. A. et al. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients. Int. J. Immunopathol. Pharmacol. 22(36), 03946320221096207 (2022).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"34444_CR31","doi-asserted-by":"crossref","unstructured":"Mocan M, Chiorescu RM, Tirnovan A, Buksa BS, Farca\u0219 ADJJoCM: Severe thrombocytopenia as a manifestation of COVID-19 infection. 2022, 11(4):1088.","DOI":"10.3390\/jcm11041088"},{"key":"34444_CR32","doi-asserted-by":"crossref","unstructured":"Davoodian A, Umeh C, Novatcheva E, Sassi GP, Ahaneku H, Kundu A, Novatcheva ED. Severe immune thrombocytopenia post-COVID-19: a case report. Cureus. 2021 Nov 13;13(11).","DOI":"10.7759\/cureus.19544"},{"issue":"18","key":"34444_CR33","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382(18), 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"34444_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","volume":"8","author":"C Danwang","year":"2020","unstructured":"Danwang, C. et al. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark. Res. 8(1), 37 (2020).","journal-title":"Biomark. Res."},{"issue":"2","key":"34444_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/bjh.17034","volume":"191","author":"S Bellesi","year":"2020","unstructured":"Bellesi, S. et al. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. Br. J. Haematol. 191(2), 207\u2013211 (2020).","journal-title":"Br. J. Haematol."},{"issue":"1","key":"34444_CR36","doi-asserted-by":"publisher","first-page":"e00845","DOI":"10.1128\/spectrum.00845-21","volume":"10","author":"W Aljabr","year":"2022","unstructured":"Aljabr, W. et al. Evaluation of the levels of peripheral CD3+, CD4+, and CD8+ T cells and IgG and IgM antibodies in COVID-19 patients at different stages of infection. Microbiol. Spect. 10(1), e00845-e921 (2022).","journal-title":"Microbiol. Spect."},{"key":"34444_CR37","doi-asserted-by":"crossref","unstructured":"Chong VC, Lim KGE, Fan BE, Chan SS, Ong KH, Kuperan PJBJoH: Reactive lymphocytes in patients with Covid\u201019. 2020, 189(5):844.","DOI":"10.1111\/bjh.16690"},{"issue":"1","key":"34444_CR38","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/eci.13404","volume":"51","author":"S Jimeno","year":"2021","unstructured":"Jimeno, S. et al. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur. J. Clin. Invest. 51(1), e13404 (2021).","journal-title":"Eur. J. Clin. Invest."},{"issue":"61","key":"34444_CR39","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.1126\/sciimmunol.abg5669","volume":"6","author":"V Mallajosyula","year":"2021","unstructured":"Mallajosyula, V. et al. CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19. Sci. Immunol. 6(61), 5669 (2021).","journal-title":"Sci. Immunol."},{"issue":"11","key":"34444_CR40","doi-asserted-by":"publisher","first-page":"e15509","DOI":"10.7717\/peerj.15509","volume":"23","author":"P Liana","year":"2023","unstructured":"Liana, P. et al. CD4+ and CD8+ cell counts are significantly correlated with absolute lymphocyte count in hospitalized COVID-19 patients: A retrospective study. PeerJ 23(11), e15509 (2023).","journal-title":"PeerJ"},{"issue":"11","key":"34444_CR41","first-page":"544639","volume":"1","author":"B Diao","year":"2020","unstructured":"Diao, B. et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front. Immunol. 1(11), 544639 (2020).","journal-title":"Front. Immunol."},{"key":"34444_CR42","volume":"133","author":"C Lei","year":"2020","unstructured":"Lei, C. et al. Wang JJJoCV: Factors associated with clinical outcomes in patients with coronavirus disease 2019 in Guangzhou. China. 133, 104661 (2020).","journal-title":"China."},{"issue":"1","key":"34444_CR43","first-page":"9764002","volume":"2022","author":"DR Beserra","year":"2022","unstructured":"Beserra, D. R. et al. Upregulation of PD-1 expression and high sPD-L1 levels associated with COVID-19 severity. J. Immunol. Res. 2022(1), 9764002 (2022).","journal-title":"J. Immunol. Res."},{"issue":"1","key":"34444_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.it.2020.11.002","volume":"42","author":"P de Candia","year":"2021","unstructured":"de Candia, P., Prattichizzo, F., Garavelli, S. & Matarese, G. T cells: Warriors of SARS-CoV-2 infection. Trends Immunol. 42(1), 18\u201330 (2021).","journal-title":"Trends Immunol."},{"issue":"3","key":"34444_CR45","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","volume":"18","author":"S Varchetta","year":"2021","unstructured":"Varchetta, S. et al. Unique immunological profile in patients with COVID-19. Cell. Mol. Immunol. 18(3), 604\u2013612 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"34444_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.thromres.2020.07.047","volume":"195","author":"HH Yu","year":"2020","unstructured":"Yu, H. H., Qin, C., Chen, M., Wang, W. & Tian, D. S. D-dimer level is associated with the severity of COVID-19. Thromb. Res. 195, 219\u2013225 (2020).","journal-title":"Thromb. Res."},{"issue":"7","key":"34444_CR47","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han, H. et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin. Chem. Lab. Med. 58(7), 1116\u20131120 (2020).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"34444_CR48","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","volume":"116","author":"L Chen","year":"2020","unstructured":"Chen, L., Li, X., Chen, M., Feng, Y. & Xiong, C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc. Res. 116(6), 1097\u20131100 (2020).","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"34444_CR49","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/jmv.26097","volume":"92","author":"N Ali","year":"2020","unstructured":"Ali, N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J. Med. Virol. 92(11), 2409\u20132411 (2020).","journal-title":"J. Med. Virol."},{"issue":"5","key":"34444_CR50","first-page":"411","volume":"49","author":"XH Yao","year":"2020","unstructured":"Yao, X. H. et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua bing li xue za zhi Chinese journal of pathology 49(5), 411\u2013417 (2020).","journal-title":"Zhonghua bing li xue za zhi Chinese journal of pathology"},{"issue":"9","key":"34444_CR51","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/S2666-5247(23)00171-4","volume":"4","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: A prospective cohort study. The Lancet Microbe 4(9), e692\u2013e703 (2023).","journal-title":"The Lancet Microbe"},{"issue":"5","key":"34444_CR52","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","volume":"52","author":"T Hirano","year":"2020","unstructured":"Hirano, T. & Murakami, M. COVID-19: A new virus, but a familiar receptor and cytokine release syndrome. Immunity 52(5), 731\u2013733 (2020).","journal-title":"Immunity"},{"issue":"1","key":"34444_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb, S. et al. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 19(1), 92 (2022).","journal-title":"Virol. J."},{"key":"34444_CR54","doi-asserted-by":"crossref","unstructured":"Sarhan WM, Shalaby SM, Zidan N, Elhawary A, Ismail N, Makani V, Abd elnour HM: Cytokine Storm in COVID-19 Patients: Association between cytokines and disease severity %J Zagazig Univ. Med. J. 2021, 27(6):1640\u20131653.","DOI":"10.21608\/zumj.2021.76794.2237"},{"issue":"6","key":"34444_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes, E. A. & Haghbayan, H. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev. Med. Virol. 30(6), 1\u20139 (2020).","journal-title":"Rev. Med. Virol."},{"key":"34444_CR56","doi-asserted-by":"crossref","unstructured":"Rostamian A, Ghazanfari T, Arabkheradmand J, Edalatifard M, Ghaffarpour S, Salehi M, Raeeskarami S-R, Aliabadi M, Chenary M, Mirsharif E et al: Interleukin-6 as a Potential Predictor of COVID-19 Disease Severity in Hospitalized Patients and its Association with Clinical Laboratory Routine Tests. Immunoregulation 2020:29\u201336.","DOI":"10.32598\/IMMUNOREGULATION.3.1.4"},{"key":"34444_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641295","volume":"12","author":"E Keewan","year":"2021","unstructured":"Keewan, E., Beg, S. & Naser, S. A. Anti-TNF-\u03b1 agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling. Front. Immunol. 12, 641295 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"34444_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12959-022-00428-5","volume":"20","author":"SES Abd El-Ghani","year":"2022","unstructured":"Abd El-Ghani, S. E. S. et al. Serum interleukin 1\u03b2 and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients?(a cross-sectional study). Thromb. J. 20(1), 77 (2022).","journal-title":"Thromb. J."},{"key":"34444_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cytogfr.2021.10.007","volume":"63","author":"F Ahmad","year":"2022","unstructured":"Ahmad, F., Kannan, M. & Ansari, A. W. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev. 63, 58\u201368 (2022).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"34444_CR60","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","volume":"20","author":"L Carsana","year":"2020","unstructured":"Carsana, L. et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-centre descriptive study. Lancet. Infect. Dis 20(10), 1135\u20131140 (2020).","journal-title":"Lancet. Infect. Dis"},{"issue":"7","key":"34444_CR61","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","volume":"53","author":"S Kang","year":"2021","unstructured":"Kang, S. & Kishimoto, T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp. Mol. Med. 53(7), 1116\u20131123 (2021).","journal-title":"Exp. Mol. Med."},{"key":"34444_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.968991","volume":"13","author":"A Giannella","year":"2022","unstructured":"Giannella, A. et al. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients. Front. Immunol. 13, 968991 (2022).","journal-title":"Front. Immunol."},{"issue":"6","key":"34444_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234765","volume":"15","author":"MC Grant","year":"2020","unstructured":"Grant, M. C. et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE 15(6), e0234765 (2020).","journal-title":"PLoS ONE"},{"key":"34444_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.815651","volume":"12","author":"P Mart\u00ednez-Fleta","year":"2021","unstructured":"Mart\u00ednez-Fleta, P. et al. A differential signature of circulating miRNAs and cytokines between COVID-19 and community-acquired pneumonia uncovers novel physiopathological mechanisms of COVID-19. Front. Immunol. 12, 815651 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"34444_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05850","volume":"7","author":"K Sun","year":"2021","unstructured":"Sun, K., Gu, L., Ma, L. & Duan, Y. Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2. Heliyon 7(1), e05850 (2021).","journal-title":"Heliyon"},{"issue":"5","key":"34444_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100287","volume":"2","author":"MR Filbin","year":"2021","unstructured":"Filbin, M. R. et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep. Med. 2(5), 100287 (2021).","journal-title":"Cell Rep. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34444-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:03:17Z","timestamp":1769688197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34444-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34444"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34444-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out according to the Declaration of Helsinki. Informed consent was taken from all the study subjects. The study was approved by the research ethical committee of the Faculty of Medicine, Minia University (Approval No.107:01\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4093"}}